Results 131 to 140 of about 16,243 (160)

Systemic EP4 receptor agonist and Arginase‐1 therapy in a murine model of chronic asthma and influenza virus‐induced asthma exacerbation

open access: yesBritish Journal of Pharmacology, Volume 182, Issue 12, Page 2803-2820, June 2025.
Background and Purpose Myeloid‐derived suppressor cells (MDSCs) play important roles in the pathogenesis of asthma. Recent studies demonstrate that their function can be modulated by different pharmacological approaches. In this study, we focussed on the effects of systemically administered prostaglandin EP4 receptor agonist L‐902,688 and pegylated ...
Tim Lange   +7 more
wiley   +1 more source

Post‐Mortem Community Surveillance of COVID‐19: Implementation and Evaluation of a Pilot System in the Funeral Sector in England, UK, January 2021 to February 2022

open access: yesInfluenza and Other Respiratory Viruses, Volume 19, Issue 6, June 2025.
ABSTRACT Background Early in the COVID‐19 pandemic, due to limited testing, a potential gap in capturing SARS‐CoV‐2‐positive community deaths was identified. Post‐mortem testing for respiratory viruses had never been implemented in the United Kingdom. Aim Through implementing and evaluating a pilot, we aimed to establish feasibility and acceptability ...
Hannah E. Emmett   +6 more
wiley   +1 more source

Evaluating the Impact of Different Methods on the Timing and Duration of RSV Epidemics: Analysis of Surveillance Data From the GERi (Global Epidemiology of RSV in Hospitalized and Community Care) Study

open access: yesInfluenza and Other Respiratory Viruses, Volume 19, Issue 6, June 2025.
ABSTRACT Background We previously reviewed methods for estimating the timing of respiratory syncytial virus (RSV) epidemics. This study examines the impact of various estimation methods on determining the start, end, duration, and capture rate of RSV epidemics.
Lisa Staadegaard   +18 more
wiley   +1 more source

In‐Hospital Mortality and Severe Respiratory and Renal Outcomes—A Territory‐Wide Comparison Between RSV and Influenza

open access: yesInfluenza and Other Respiratory Viruses, Volume 19, Issue 6, June 2025.
ABSTRACT Introduction Respiratory syncytial virus (RSV) and influenza virus are important respiratory viruses. Although RSV vaccines have been developed and recommended for patients aged ≥ 60, there is limited data on the clinical impact among the non‐elderly population.
Wang Chun Kwok   +7 more
wiley   +1 more source

Early‐life allergic sensitization and respiratory infection—Two hits on lung function?

open access: yesPediatric Allergy and Immunology, Volume 36, Issue 6, June 2025.
Abstract Background Allergic sensitization and respiratory infections commonly occur in childhood. Interplay between them in asthma development is known as the ‘two‐hit’ hypothesis. There has been no previous investigation of this hypothesis on adult lung function.
Vikas Wadhwa   +9 more
wiley   +1 more source

RESPIRATORY SYNCYTIAL VIRUS

open access: bronze, 1982
Caroline B. Hall
openalex   +1 more source

Asymptomatic SARS‐CoV‐2 Infection: Association Involving the HLA‐B*15 Allele Group in Brazilian Individuals

open access: yesHLA, Volume 105, Issue 6, June 2025.
ABSTRACT The aim of this study was to investigate the influence of HLA‐A, ‐B and ‐C polymorphisms on the clinical course of SARS‐CoV‐2 infection and on the progression of COVID‐19 in a population from southeastern Brazil. This study included 478 unvaccinated individuals. Of these, 369 were hospitalised with critical/severe (n = 309) or moderate/mild (n 
Christiane Maria Ayo   +8 more
wiley   +1 more source

Poster Sessions

open access: yes
HemaSphere, Volume 9, Issue S1, June 2025.
wiley   +1 more source

Publication Only

open access: yes
HemaSphere, Volume 9, Issue S1, June 2025.
wiley   +1 more source

Common Radiological Features on Chest X‐Rays of Infants With Bronchiolitis: Do They Support Management?

open access: yes
Acta Paediatrica, Volume 114, Issue 6, Page 1478-1480, June 2025.
C. Towriss   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy